Actual costs of cancer drugs in 15 European countries
Lancet Oncol
.
2016 Jan;17(1):18-20.
doi: 10.1016/S1470-2045(15)00486-6.
Epub 2015 Dec 4.
Authors
Wim H van Harten
1
,
Anke Wind
2
,
Paolo de Paoli
3
,
Mahasti Saghatchian
4
,
Simon Oberst
5
Affiliations
1
Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands. Electronic address: w.v.harten@nki.nl.
2
Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands.
3
Centro di Riferimento Oncologico, Aviano, Italy.
4
Institut Gustave Roussy, Villejuif, France.
5
The Cambridge Cancer Centre, Cambridge, UK.
PMID:
26670093
DOI:
10.1016/S1470-2045(15)00486-6
No abstract available
MeSH terms
Antineoplastic Agents / economics*
Drug Costs*
Drug Industry / economics*
Europe
Humans
Surveys and Questionnaires
Substances
Antineoplastic Agents